CDK4 and neoplasm: Consistently, blocking Ser41 phosphorylation, either by CDK4/6 inhibition or the reconstitution of the Ser41A mutant, promotes YAP1 degradation and suppresses YAP1‐driven tumor progression (Figures 5 and S4).